EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C27H41N3O5 |
| Net Charge | 0 |
| Average Mass | 487.641 |
| Monoisotopic Mass | 487.30462 |
| SMILES | CCCC[C@H](C)[C@@H]1CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)O1 |
| InChI | InChI=1S/C27H41N3O5/c1-6-7-11-18(4)23-16-24(31)29-21(15-20-12-9-8-10-13-20)26(33)28-19(5)25(32)30-22(14-17(2)3)27(34)35-23/h8-10,12-13,17-19,21-23H,6-7,11,14-16H2,1-5H3,(H,28,33)(H,29,31)(H,30,32)/t18-,19-,21-,22+,23-/m0/s1 |
| InChIKey | ZKSLFHXTWGEITF-JIORRVSTSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Beauveria sp. (ncbitaxon:1891652) | cell suspension culture (BTO:0000221) | PubMed (10092189) | Strain: FO-6979 |
| Cordyceps militaris (ncbitaxon:73501) | - | PubMed (31926180) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | EC 2.3.1.26 (sterol O-acyltransferase) inhibitor An EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the action of acyl-CoA:cholesterol acyltransferase (EC 2.3.1.26). fungal metabolite Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds. |
| Applications: | antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. antiatherogenic agent A cardiovascular drug that prevents atherogenesis, the accumulation of lipid-containing plaques on the innermost layers of the arteries. Compare with antiatherosclerotic agent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| beauveriolide I (CHEBI:180490) has role antiatherogenic agent (CHEBI:50855) |
| beauveriolide I (CHEBI:180490) has role antiatherosclerotic agent (CHEBI:145947) |
| beauveriolide I (CHEBI:180490) has role EC 2.3.1.26 (sterol O-acyltransferase) inhibitor (CHEBI:64696) |
| beauveriolide I (CHEBI:180490) has role fungal metabolite (CHEBI:76946) |
| beauveriolide I (CHEBI:180490) has role geroprotector (CHEBI:176497) |
| beauveriolide I (CHEBI:180490) is a cyclodepsipeptide (CHEBI:35213) |
| beauveriolide I (CHEBI:180490) is a macrocycle (CHEBI:51026) |
| IUPAC Name |
|---|
| (3R,6S,9S,13S)-9-benzyl-13-[(2S)-hexan-2-yl]-6-methyl-3-(2-methylpropyl)-1-oxa-4,7,10-triazacyclotridecane-2,5,8,11-tetrone |
| Manual Xrefs | Databases |
|---|---|
| 8088999 | ChemSpider |
| US2003143716 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:154491-55-1 | ChEBI |
| Citations |
|---|